IGF1 and metabolic dysfunction-associated steatotic liver disease: As demonstrated in previous studies15–18, reduced IGF-1 levels are independently associated with multiple cardiovascular risk factors, including NAFLD, insulin resistance, dyslipidemia (particularly low HDL-C) and metabolic syndrome.